Oasmia Pharmaceutical AB is owned to 21.6 percent by Alceco International S.A., a holding company in Luxembourg. Alceco International S.A. is controlled to 100 percent by Bo Cederstrand and Julian Aleksov.
|The 10 major shareholders
as of March 31, 2017
|Shares of votes
and capital (%)
|Alceco International S.A.||21.6|
|Försäkringsaktiebolaget Avanza Pension||8.8|
|Danske Bank International S.A.||4.1|
|Nordnet Pensionsförsäkring AB||3.9|
|JP Morgan Bank Luxembourg||2.6|
|Bank of New York||2.1|
|J P Morgan Securities LLC||1.6|
|A M Karlsson i Kvicksund AB||1,0|
The above is based on the number of shares registered at Euroclear on April 30, which was 119,039,310. As announced by the company on May 1, the number of shares in May increased to 126,098,166 after conversion of convertibles, which then issued 7,058,856 shares.